Why Collegium Pharmaceutical (COLL) Stock Is Trading Lower Today [Yahoo! Finance]
Collegium Pharmaceutical, Inc. (COLL)
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.collegiumpharma.com
Company Research
Source: Yahoo! Finance
reported fourth-quarter earnings and revenue that fell short of analysts' expectations. The specialty pharmaceutical company posted adjusted earnings of $2.04 per share, which missed the analyst estimate of $2.14. Revenue for the quarter also did not meet forecasts, coming in at $205.45 million versus the consensus estimate of $207.07 million. When a company's financial results do not meet Wall Street's predictions, it can lead to a drop in its stock price as investors react to the news. The sell-off was significant enough that the shares entered what traders refer to as oversold territory. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Collegium Pharmaceutical? Access our full analysis report here, it's free What Is The Market Telling Us Collegium Pharmaceutical's shares are somewhat volatile and have had 11 moves greater than 5% over the last year. In that context, today's move indica
Show less
Read more
Impact Snapshot
Event Time:
COLL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COLL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COLL alerts
High impacting Collegium Pharmaceutical, Inc. news events
Weekly update
A roundup of the hottest topics
COLL
News
- Collegium Pharmaceutical (COLL) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "buy (b-)" to "hold (c+)".MarketBeat
- Collegium to Present New Real-World Data at PainConnect 2026GlobeNewswire
- Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community [Yahoo! Finance]Yahoo! Finance
- Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD CommunityGlobeNewswire
- Collegium to Participate in Upcoming Investor ConferencesGlobeNewswire
COLL
Earnings
- 2/26/26 - Beat
COLL
Sec Filings
- 3/5/26 - Form 4
- 3/3/26 - Form 144
- 2/26/26 - Form 10-K
- COLL's page on the SEC website